Dietary Salt Intake and Cardiovascular Disease: Summarizing the Evidence

Abstract

We present a narrative review of the literature linking dietary salt intake with cardiovascular health outcomes in humans and list the tools and strategies to reduce salt intake at the population level. There is a strong agreement among experts that dietary salt intake should be reduced, targeting average population levels less than 5 g per day. The main aim of this reduction is a decline in cardiovascular morbidity and mortality. Experimental data clearly show that reducing salt intake lowers blood pressure. Considering that high blood pressure is a major cardiovascular risk factor, this provides indirect evidence that salt reduction should improve cardiovascular health. 1 There is also recent direct evidence that reducing salt intake reduces the incidence of cardiovascular disease. Direct evidence linking reduction in salt intake with decreased overall and cardiovascular mortality is more limited and disputed and the data for stroke are inconsistent. Thus, there is a debate on the quality and nature of the available evidence, particularly on the magnitude of the benefit provided by the achievable reduction in salt intake. Yet, there are no known deleterious consequences of the proposed reduction in salt intake. Several countries have adopted policies aiming at reducing salt intake in the general population. The relevant tools and strategies are directed to both the food industry and the consumers. At the industry level, the most efficient measure is legislation on the salt content of selected foods, an approach much more (cost) effective than voluntary reductions. None of the interventions aiming at reducing salt intake has been rigorously evaluated. In view of recurrent controversies, any intervention in this field should be accompanied by an appropriate monitoring and evaluation program.

Effects of walnut intake on blood pressure: A systematic review and meta‐analysis of randomized controlled trials

“…Hypertension or high blood pressure (BP) is a key modifiable risk factor for cardiovascular diseases (CVD), hence being the main cause of global morbidity and mortality (Bochud, Marques‐Vidal, Burnier, & Paccaud, 2011; Forouzanfar et al, 2016; Lawes, Vander Hoorn, & Rodgers, 2008). Around 40% of the global population has raised BP and the global burden of hypertension is estimated to exceed 1.6 billion by 2025 (Egan, Kjeldsen, Grassi, Esler, & Mancia, 2019), leading to a subsequent increase in disability‐adjusted life years and deaths related to hypertension (Forouzanfar et al, 2017).…”

Sodium intake and blood pressure in children with clinical conditions: A systematic review with meta‐analysis

“…Hypertension is a major risk factor for cardiovascular disease and an important cause of morbidity and mortality worldwide . Because high sodium intake is a modifiable cause of elevated blood pressure (BP) in adults, the World Health Organization recommends sodium intake reduction in the population as a key strategy to reduce the burden of cardiovascular diseases .…”

Urinary Sodium Concentration Is an Independent Predictor of All-Cause and Cardiovascular Mortality in a Type 2 Diabetes Cohort Population

“…Nevertheless clinical trials have demonstrated that reduced sodium intake lowered blood pressure [ 25 ]. However interventions lowering salt intake have not established a definite clinical benefit either in the general or more particularly in the T2D population [ 26 – 28 ]. The low Na excretion may be due to insulin therapy, which is more frequent in the low tertile of U Na .…”